Breast cancer drug rejected by NHS over high cost – The Voice Online

Posted on April 23, 2014

Breast cancer drug rejected by NHS over high cost The Voice Online The National Institute for Health and Care Excellence (Nice) has blamed manufacturers Roche for the high cost of Kadcyla (generic name trastuzumab emtansine), but their decision has been criticised by a number of breast cancer charities who say?…

The rest is here:
Breast cancer drug rejected by NHS over high cost – The Voice Online

Tags: , , , , , , , , ,

Leave a Reply